advanced hcc: what’s next?
Published 5 years ago • 40 plays • Length 5:10Download video MP4
Download video MP3
Similar videos
-
7:29
understanding how best to sequence in advanced hcc
-
8:59
advanced hcc: case discussion on immunotherapy
-
8:25
analyzing the immunotherapy landscape for advanced hcc
-
5:57
treatment options for locally advanced hcc
-
1:43
treatment for advanced-stage hcc
-
1:35:10
mapping the optimal treatment route in hcc: best practices
-
45:53
hepatocellular carcinoma
-
52:44
the 2022 bclc update –what has changed and what are the limitations - prof m bernon
-
3:49
hepatocellular carcinoma (hcc) - what is the most common cause of hepatocellular carcinoma? 247nht
-
1:40
comparing sorafenib and lenvatinib for the frontline treatment of advanced hcc
-
1:31
liver cancer staging
-
8:50
first-line therapy in advanced hcc
-
6:40
systemic therapy for advanced hcc
-
8:01
emerging therapies in advanced hcc
-
5:50
managing toxicities in advanced hcc
-
1:37:24
evidence-based treatment selection and sequencing in advanced hcc
-
5:40
sorafenib initiation after tace in hcc
-
29:27
a new era in treating patients with advanced hcc: 2nd line treatment selection and when to switch?
-
1:52
exploring current and upcoming therapies for hepatocellular carcinoma
-
2:19
the future of treatment in hepatocellular carcinoma
-
4:35
locoregional therapies for advanced hcc
-
1:05
dr. kim on role of frontline immunotherapy in advanced hcc